Drugmakers rush to sign deals on first day of industry conference January 13, 2025 AbbVie has obtained the option to license a new blood cancer drug candidate from Simcere Pharmaceutical's unit ...

AbbVie (ABBV) announced that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a ...